MedPath

comparison of changes in blood pressure following supplementation of either of the two drugs named oxytocin and carbetocin in surgeries done in pregnant mothers following the delivery of the baby.

Phase 3
Conditions
Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Registration Number
CTRI/2024/05/067030
Lead Sponsor
oorul Aashika A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Parturient acceptance

2.ASA status 2 and 3

3.Age between 20-30 yrs.

4.Parturient of term gestation undergoing elective lower segment cesarean section under spinal anesthesia

Exclusion Criteria

1.Absolute contraindications for spinal anesthesia

2.Combined spinal epidural anesthesia

3.Short stature <145cm and BMI > 40

4.Conditions associated with increased level of PPH risk (placenta previa, placentalabruption, multiple gestation)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary objective of this study is to compare the mean arterial blood pressure variation following administration of oxytocin and carbetocin in lower segment cesarean section.Timepoint: Baseline, 1,3,5,10 minutes and every 2nd minute following delivery of baby till 20 minutes
Secondary Outcome Measures
NameTimeMethod
The secondary objective focusses on <br/ ><br>1.Heart rate variations occurring between oxytocin and carbetocin <br/ ><br>2.Requirement of vasopressor - phenylephrine <br/ ><br>3.Clinical estimation of blood loss <br/ ><br>4.Side effects and complications of oxytocin and carbetocin <br/ ><br>Timepoint: Baseline, 1,3,5,10 minutes and every 2nd minute following delivery of baby till 20 minutes
© Copyright 2025. All Rights Reserved by MedPath